Data Insights
Showing 2 results out of 2
Data Insights
Q4 2023 update: digitalization related private equity activity in the pharmaceutical industry
Analysis of the key themes driving private equity deal activity reveals that digitalization accounted for 2 pharmaceutical deals announced in...
Data Insights
Q4 2023 update: digitalization related M&A activity in the pharmaceutical industry
Analysis of the key themes driving M&A activity reveals that digitalization accounted for 14 pharmaceutical deals announced in Q4 2023,...